- Healthcare Trust of America stock price today and history
Healthcare Trust of America (HTA) stock prices updated...
Please, Signup (Login) to subscribe or trade (demo)
Healthcare Trust of America stock price, HTA
Healthcare Trust of America stock chart:
Healthcare Trust of America close price: 31.29
Stock price forecast:
DOWN TO -4.92%
Total forecasts: 90
Reached: 75 (83.33%)
Total Win: 56.32 (194.59%)
Showing 1-10 of 481 items.
|Date of Forecast||Stock Price||Target Price||Forecast Reached Date|
Healthcare Trust of America latest news:
BRIEF-Molina Healthcare to receive $75 mln termination fee following Aetna ending Humana merger
* Molina Healthcare - as result of Aetna ending Humana
merger and plan to sell medicare advantage assets to Molina,
Molina will get $75 million as termination fee
Source text: (http://bit.ly/2knLvt2)
Further company coverage:
Humana to exit Obamacare exchanges, buy back $2B in stock
After its merger with Aetna was called off Tuesday, Humana Inc. said that it will stop offering commercial health insurance to individuals on state exchanges and buy back $2 billion in stock. Humana, which said it is owed a $1 billion breakup fee from Aetna, said it will focus on care for people living with chronic conditions moving forward. The company said it will give up its business of offering individual commercial medical coverage on the 11 state exchanges in which it currently operates as of Jan. 1, 2018. "As an independent company, we will continue to innovate and sharpen our focus on the local healthcare experience of all our members, especially seniors living with chronic conditions," Chief Executive Bruce Broussard said in the announcement. Humana plans to repurchase $2 billion worth of shares, with an accelerated repurchase of $1.5 billion in the current quarter. Humana stock, which closed with a 0.4% decline at $205.97 Tuesday, moved higher to $207 in late trading after the announcement.Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
Cigna terminates Anthem merger deal, seeks nearly $15 billion in restitution
Cigna Corp. disclosed in filing Tuesday that it has terminated the merger deal with Anthem Inc. , six days after a court ruling to enjoin the proposed merger, and about 19 months after the $48 billion merger was announced. Cigna said has filed suit against Anthem, seeking a $1.85 billion reverse termination fee and more than $13 billion in additional damages, which includes the amount of premium Cigna shareholders did not realize. Cigna said it decided to terminate the deal after a district court found that the merger would decrease competition and choices for consumers. Cigna's decision marked the second big healthcare merger that was terminated Tuesday, after Aetna Inc. and Humana Inc. agreed to end their $34 billion merger, also after 19 months. Cigna said Tuesday that it while it was "disappointed" in the merger's failure, it was moving ahead by expanding its stock repurchase program to a total of $3.7 billion. The company said its 2017 outlook for adjusted earnings growth will get a boost from the "significant" capital available for deployment. Cigna's stock was up 0.4% in afternoon trade, while Anthem shares slipped 0.2%. Over the past 12 months, Cigna's stock has gained 12%, Anthem shares have rallied 34% and the S&P 500 has gained 25%.Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
BRIEF-ViiV Healthcare announces positive phase III results for two-drug regimen of Dolutegravir and Rilpivirine
* ViiV Healthcare announces detailed positive phase III
results for investigational two-drug regimen of dolutegravir and
rilpivirine for HIV treatment
Siemens considers U.S. listing of healthcare arm: CEO in Euro am Sonntag
German industrial group Siemens is considering listing its $15 billion healthcare business in the United States to take advantage of company valuations that are higher than in Europe, its chief executive told a German newspaper.
BRIEF-Community Healthcare Trust sets quarterly dividend of $0.3875 per share
* Community Healthcare Trust Incorporated Announces
Increased Fourth Quarter Dividend
McKesson to buy CoverMyMeds for $1.1B, reports sales slightly below expectations
McKesson Corp. said late Wednesday it had agreed to buy privately held CoverMyMeds for $1.1 billion, saying the acquisition of the Columbus, Ohio, software company will "strengthen our technology offerings." McKesson also reported fiscal third-quarter sales slightly below Wall Street expectations. The company said it earned $633 million, or $2.86 a share, in the quarter, compared with $634 million, or $2.71 a share, a year ago. Adjusted for one-time items, McKesson earned $3.18 a share in the quarter. Revenue reached $50.1 billion, up 5% from $47.9 billion a year ago, the San Francisco-based company said. Analysts polled by FactSet expected the healthcare services and IT company to report adjusted earnings of $2.91 a share on sales of $50.5 billion. Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
Abbott gets U.S. antitrust approval to buy St. Jude Medical
WASHINGTON (Reuters) - Healthcare company Abbott Laboratories has won U.S. antitrust approval for its proposed $25 billion acquisition of medical device maker St. Jude Medical Inc , the U.S. Federal Trade Commission said on Tuesday.
Mid-America Apartment, AmSurg to join S&P 500
Mid-America Apartment Communities Inc. and AmSurg Corp. will join the S&P 500 index , according to S&P Dow Jones Indices late Tuesday. The adds to the index will occur after the close of trading on Thursday, S&P said. On the large-cap index, Mid-America will replace Owens-Illinois Inc. and AmSurg, which is acquiring Envision Healthcare Holdings Inc. , will replace Legg Mason Inc. . Shares of Mid-America were up less than 0.1% at $93.83 while shares of AmSurg were up 0.3% at $67.60 after hours.Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
Johnson & Johnson approaches Actelion about takeover deal
U.S. healthcare company Johnson & Johnson (JNJ) said on Friday it was in preliminary talks with Actelion about a potential takeover of Europe's largest biotech firm, currently valued at about $20 billion. Lung disease specialist Actelion confirmed it had been approached and said there was no certainty a deal would occur.
Heartland Payment SystemsHPY
Hecla Mining CompanyHL
Hecla Mining CompanyHL^B
Helix Energy Solutions GroupHLX
Helmerich & PayneHP
Hercules Technology Growth CapitalHTGC